Stock Market Update

1 Mins read

As the U.S. stock markets prepare to open, there are a few notable movements in pre-market trading. Elanco Animal Health Inc. (ELAN) is up by 7.5%, while AGCO Corp. (AGCO) has seen a 5.1% increase.

There are also positive gains from Rocket Cos. Inc. (RKT), Paramount Global Cl B (PARA), and CarMax Inc. (KMX), all experiencing gains of at least 2%. However, Iridium Communications Inc. (IRDM) and HP Inc. (HPQ) have seen declines of 4.2% and 3.7% respectively.

Looking at the futures market, the S&P 500 futures are currently down by 0.11%, while the Dow Jones Industrial Average futures have fallen by 0.09%. Additionally, the Cboe Volatility Index futures are down by 0.85%.

In commodities news, Brent crude oil futures are up by 0.08%, whereas gold futures have experienced a slight decline of 0.08%. Notably, Bitcoin has dropped by 1.70% and is valued at $26,049.

Additionally, the 10-Year Treasury yield has risen to 4.493%.

During the previous regular trading session, there was a slight decrease in the S&P 500 and Dow indexes, down by 0.23% and 0.31%, respectively. The Asian stock market showed mixed results, with Japan’s NIKKEI 225 Index seeing an increase of 0.85%, while China’s Shanghai Composite Index saw a decline of 0.54%.

As for the European market, stocks are currently in negative territory, with the STOXX Europe 600 Index dropping by 0.49% and the FTSE 100 Index declining by 0.50% from the previous close.

U.S. stock markets will open for trading at 9:30 a.m. ET. Stay updated on the latest developments throughout the trading day.

Related posts

GitLab Stock Surges on First Ever Adjusted Operating Profit

1 Mins read
GitLab’s stock experienced a significant surge on Tuesday following the announcement of its first ever adjusted operating profit. Despite this positive development,…

Virgin Galactic Faces Stock Decline Amid Founder's Money Decision

2 Mins read
Virgin Galactic stock experienced a sharp decline in early trading on Monday due to founder Richard Branson’s announcement that he won’t be…

EyePoint Pharmaceuticals Announces Positive Results in Phase 2 Trial for Macular Degeneration Treatment

1 Mins read
EyePoint Pharmaceuticals, a Massachusetts-based company, revealed exciting news on Monday regarding the second-phase trial of its investigational treatment for macular degeneration. The…

Leave a Reply

Your email address will not be published. Required fields are marked *

− 2 = 4